Lonza Group AG
LONN
Rank in Stocks
#449
Lonza Group AG, together with its subsidiaries, operates as a contract... Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Share Price
$761.37
Market Cap
$53.18B
Change (1 day)
0.61%
Change (1 year)
8.22%
Country
CH
Trade Lonza Group AG (LONN)
Category
Healthcare
Stock split history for Lonza Group AG (LONN)
Lonza Group AG stock (symbol: LONN) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 22, 2026.
One LONN share bought prior to Oct 22, 2026 would equal to 0 LONN shares today.
The most recent stock split occurred on Oct 22, 2026.
One LONN share bought prior to Oct 22, 2026 would equal to 0 LONN shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 1 | x100 |
BE
|
